Human Factor XIII Deficient Plasma

• Description:

  Human Factor XIII Deficient Plasma_x000D_ Catalog number: B2014479_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Amount: 1 mL_x000D_ Molecular Weight or Concentration: N/A_x000D_ Supplied as: Plasma_x000D_ Applications: molecular tool for various biochemical applications_x000D_ Storage: -20°C_x000D_ Keywords: Human Factor XIII Deficient Plasma, Frozen_x000D_ Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ References:_x000D_ 1: McDonagh J, McDonagh RP Jr, Delâge JM, Wagner RH. Factor XIII in human plasma and platelets J Clin Invest. 1969 May;48(5):940-6._x000D_ 2: Tahlan A, Ahluwalia J. Factor XIII: congenital deficiency factor XIII, acquired deficiency, factor XIII A-subunit, and factor XIII B-subunit Arch Pathol Lab Med. 2014 Feb;138(2):278-81._x000D_ 3: Caudill JS, Nichols WL, Plumhoff EA, Schulte SL, Winters JL, Gastineau DA, Rodriguez V. Comparison of coagulation factor XIII content and concentration in cryoprecipitate and fresh-frozen plasma Transfusion. 2009 Apr;49(4):765-70._x000D_ 4: Schmidt DE, Halmin M, Wikman A, Östlund A, Ã…gren A. Relative effects of plasma, fibrinogen concentrate, and factor XIII on ROTEM coagulation profiles in an in vitro model of massive transfusion in trauma Scand J Clin Lab Invest. 2017 Oct;77(6):397-405._x000D_ 5: Jain S, Acharya SS. Management of rare coagulation disorders in 2018 Transfus Apher Sci. 2018 Dec;57(6):705-712._x000D_ 6: Maaloul I, Medhaffer M, Louhichi N, Krichen I, Alibi S, Kmiha S, Aloulou H, Fakhfakh F, Elloumi M, Kallel C, Hachicha M. Factor XIII deficiency in south of Tunisia Blood Coagul Fibrinolysis. 2017 Sep;28(6):485-489._x000D_ 7: Adam EH, Kreuer S, Zacharowski K, Weber CF, Wildenauer R. [Factor XIII : Pharmacodynamic and pharmacokinetic characteristics] Anaesthesist. 2017 Jan;66(1):52-59._x000D_ 8: Bannow BS, Konkle BA. Inherited Bleeding Disorders in the Obstetric Patient Transfus Med Rev. 2018 Oct;32(4):237-243._x000D_ 9: Peyvandi F, Garagiola I, Biguzzi E. Advances in the treatment of bleeding disorders J Thromb Haemost. 2016 Nov;14(11):2095-2106._x000D_ 10: Asahina T, Kobayashi T, Takeuchi K, Kanayama N. Congenital blood coagulation factor XIII deficiency and successful deliveries: a review of the literature Obstet Gynecol Surv. 2007 Apr;62(4):255-60. _x000D_ _x000D_ Products Related to Human Factor XIII Deficient Plasma can be found at Biofluids

• Short Description:

  Catalog Number: B2014479 (1 mL)_x000D_ Human Factor XIII Deficient Plasma is a high quality human Factor XIII deficient plasma (frozen). This product has been used as molecular tool for various biochemical applications. It has also been used in a wide array of other chemical and immunological applications. Custom bulk amounts of this product are available upon request._x000D_ _x000D_

• Weight:

  0.15

• Length:

  2

• Width:

  0.5

• Height :

  0.5